FEMY

Femasys Inc.

1.33 USD
+0.01 (+0.76%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Femasys Inc. stock is down -19.88% since 30 days ago. The next earnings date is May 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 April’s closed higher than March. 100% of analysts rate it a buy.

About Femasys Inc.

Femasys Inc. focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec. FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing, also commercializes FemVue saline-air device.

  • Chardan Capital
    Mon Apr 1, 08:24
    buy
    confirm
  • HC Wainwright & Co.
    Mon Apr 1, 06:41
    buy
    confirm